|
|
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
|
|
Large accelerated filer ☐
|
|
Non-accelerated filer ☐
|
|
|
|
|
|
|
Emerging growth company
|
|
|
|
International Financial Reporting
Standards as issued by the
International Accounting Standards Board ☐
|
Other ☐
|
Number | Description |
101.INS | Inline XBRL Instance Document |
101.SCH | Inline XBRL Taxonomy Extension Schema Document |
101.PRE | Inline XBRL Taxonomy Presentation Linkbase Document |
101.CAL | Inline XBRL Taxonomy Calculation Linkbase Document |
101.LAB | Inline XBRL Taxonomy Label Linkbase Document |
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
By: /s/ Eyal Harari |
Eyal Harari |
Chief Executive Officer |
|
Page
|
|
|
Reports of Independent Registered Public Accounting Firm (PCAOB ID No.
|
F-2 - F-4
|
|
F-5 - F-6
|
|
|
F-7
|
|
|
F-8
|
|
|
F-9 – F-10
|
|
|
F-11 - F-43
|
![]() |
Kost Forer Gabbay & Kasierer
144 Menahem Begin Road, Building A
Tel-Aviv 6492102, Israel
|
Tel: +972-3-6232525
Fax: +972-3-5622555
ey.com
|
![]() |
Kost Forer Gabbay & Kasierer
144 Menahem Begin Road, Building A
Tel-Aviv 6492102, Israel
|
Tel: +972-3-6232525
Fax: +972-3-5622555
ey.com
|
|
|
|
Revenue Recognition
|
|
Description of the Matter
|
|
As described in Note 2m to the consolidated financial statements, the Company derives its revenues mainly from sales of products, related maintenance and support services and professional services. The Company’s contracts with customers often contain multiple performance obligations which are accounted for separately when they are distinct. The Company allocates the transaction price to the distinct performance obligations on a relative standalone selling price basis and recognizes revenue when control is transferred. Product revenues are recognized at the point in time when the product has been delivered. The Company recognizes revenues from maintenance and support services ratably over the term of the applicable maintenance and support agreement. Revenues from professional services are recognized, when the services are provided.
Auditing the Company’s determination of the stand-alone selling price was complex and required judgment due to the subjectivity of the assumptions that were used in developing the stand-alone selling price of distinct performance obligations.
|
|
How We Addressed the Matter in Our Audit
|
|
We obtained an understanding, evaluated the design and tested the operating effectiveness of internal controls over the determination of the stand-alone selling prices.
To test management’s determination of stand-alone selling price for each performance obligation, we performed procedures to evaluate the methodology applied. We evaluated the Company's analysis of stand-alone selling price, including reading sample of executed contracts to understand and evaluate management’s identification of significant terms, tested the accuracy of the underlying data and calculations and the application of that methodology to the sampled contracts. We tested the reasonableness of factors considered by management, such as historical sales, allocation of expenses, and appropriate margins. We also tested the mathematical accuracy of management’s calculations of revenue.
Finally, we assessed the appropriateness of the related disclosures in the consolidated financial statements.
|
|
We have served as the Company’s auditor since 2006.
|
||
|
Tel-Aviv, Israel
|
/s/ KOST FORER GABBAY & KASIERER
|
|
March 26, 2026 |
A member of EY Global
|
![]() |
Kost Forer Gabbay & Kasierer
144 Menahem Begin Road, Building A
Tel-Aviv 6492102, Israel
|
Tel: +972-3-6232525
Fax: +972-3-5622555
ey.com
|
|
/s/
|
|
|
A member of EY Global
|
|
|
|
|
|
March 26, 2026
|
|
December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS:
|
||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Restricted deposits
|
|
|
||||||
|
Short-term bank deposits
|
|
|
||||||
|
Available-for-sale marketable securities
|
|
|
||||||
|
Trade receivables, net (net of allowance for credit losses of $
|
|
|
||||||
|
Other receivables and prepaid expenses
|
|
|
||||||
|
Inventories
|
|
|
||||||
|
Total current assets
|
|
|
||||||
|
NON-CURRENT ASSETS:
|
||||||||
|
Severance pay fund
|
|
|
||||||
|
Restricted deposit
|
|
|
||||||
|
Operating lease right-of-use assets
|
|
|
||||||
|
Other assets
|
|
|
||||||
|
Property and equipment, net
|
|
|
||||||
|
Intangible assets, net
|
|
|
||||||
|
Goodwill
|
|
|
||||||
|
Total non-current assets
|
|
|
||||||
|
Total assets
|
$
|
|
$
|
|
||||
| F - 5 |
|
December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
LIABILITIES AND SHAREHOLDERS' EQUITY
|
||||||||
|
CURRENT LIABILITIES:
|
||||||||
|
Trade payables
|
$
|
|
$
|
|
||||
|
Employees and payroll accruals
|
|
|
||||||
|
Deferred revenues
|
|
|
||||||
|
Short-term operating lease liabilities
|
|
|
||||||
|
Other payables and accrued expenses
|
|
|
||||||
|
Total current liabilities
|
|
|
||||||
|
LONG-TERM LIABILITIES:
|
||||||||
|
Deferred revenues
|
|
|
||||||
|
Long-term operating lease liabilities
|
|
|
||||||
|
Accrued severance pay
|
|
|
||||||
|
Convertible debt
|
|
|
||||||
|
Total long-term liabilities
|
|
|
||||||
|
SHAREHOLDERS' EQUITY:
|
||||||||
|
Share capital -
|
||||||||
|
Ordinary shares of NIS
|
|
|
||||||
|
Additional paid-in capital
|
|
|
||||||
|
Treasury share at cost -
|
(
|
)
|
(
|
)
|
||||
|
Accumulated other comprehensive income
|
|
|
||||||
|
Accumulated deficit
|
(
|
)
|
(
|
)
|
||||
|
Total shareholders' equity
|
|
|
||||||
|
Total liabilities and shareholders' equity
|
$
|
|
$
|
|
||||
| F - 6 |
|
Year ended December 31,
|
||||||||||||
|
2025
|
2024
|
2023
|
||||||||||
|
Revenues:
|
||||||||||||
|
Products
|
$
|
|
$
|
|
$
|
|
||||||
|
Services
|
|
|
|
|||||||||
|
Total revenues
|
|
|
|
|||||||||
|
Cost of revenues:
|
||||||||||||
|
Products
|
|
|
|
|||||||||
|
Services
|
|
|
|
|||||||||
|
Total cost of revenues
|
|
|
|
|||||||||
|
Gross profit
|
|
|
|
|||||||||
|
Operating expenses:
|
||||||||||||
|
Research and development (net of grant participations of $
|
|
|
|
|||||||||
|
Sales and marketing
|
|
|
|
|||||||||
|
General and administrative
|
|
|
|
|||||||||
|
Total operating expenses
|
|
|
|
|||||||||
|
Operating income (loss)
|
|
(
|
)
|
(
|
)
|
|||||||
|
Loss from extinguishment
|
(
|
)
|
|
|
||||||||
|
Other income
|
|
|
|
|||||||||
|
Financial income, net
|
|
|
|
|||||||||
|
Income (loss) before income tax expense
|
|
(
|
)
|
(
|
)
|
|||||||
|
Income tax expense
|
|
|
|
|||||||||
|
Net income (loss)
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Basic net income (loss) per share
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Diluted net income (loss) per share
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Weighted average number of shares used in computations basic net income (loss)
|
|
|
|
|||||||||
|
Weighted average number of shares used in computations diluted net income (loss)
|
|
|
|
|||||||||
|
Unrealized gain on available-for-sale marketable securities
|
|
|
|
|||||||||
|
Unrealized gain (loss) on foreign currency cash flow hedges transactions
|
|
|
(
|
)
|
||||||||
|
Net amount reclassified to earnings from hedging transactions
|
(
|
)
|
(
|
)
|
|
|||||||
|
Total comprehensive income (loss)
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
| F - 7 |
|
Ordinary shares
|
Additional
paid-in
capital
|
Treasury
share
|
Accumulated
other
comprehensive
income (loss)
|
Accumulated
deficit
|
Total
shareholders'
equity
|
|||||||||||||||||||||||
|
Outstanding shares
|
Amount
|
|||||||||||||||||||||||||||
|
Balance as of January 1, 2023
|
|
|
|
(
|
)
|
(
|
)
|
(
|
)
|
|
||||||||||||||||||
|
Exercise of share options and restricted share units
|
|
|
(
|
)
|
|
|
|
|
||||||||||||||||||||
|
Share-based compensation
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Other comprehensive loss
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Net loss
|
-
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
|
Balance as of December 31, 2023
|
|
|
|
(
|
)
|
|
(
|
)
|
|
|||||||||||||||||||
|
Exercise of share options and restricted share units
|
|
|
(
|
)
|
|
|
|
|
||||||||||||||||||||
|
Share-based compensation
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Other comprehensive loss
|
-
|
|
|
|
(
|
) |
|
(
|
)
|
|||||||||||||||||||
|
Net loss
|
-
|
|
|
|
|
(
|
) |
(
|
) | |||||||||||||||||||
|
Balance as of December 31, 2024
|
|
|
|
(
|
)
|
|
(
|
)
|
|
|||||||||||||||||||
|
Issuance of share capital
|
|
|
|
|
||||||||||||||||||||||||
|
Exercise of share options and restricted share units
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Share-based compensation
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Other comprehensive income
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Net income
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Balance as of December 31, 2025
|
|
|
|
(
|
)
|
|
(
|
)
|
|
|||||||||||||||||||
| F - 8 |
|
Year ended December 31,
|
||||||||||||
|
2025
|
2024
|
2023
|
||||||||||
|
Cash flows from operating activities:
|
||||||||||||
|
Net income (loss)
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||||||
|
Depreciation, amortization and impairment
|
|
|
|
|||||||||
|
Share-based compensation
|
|
|
|
|||||||||
|
Capital loss
|
|
|
|
|||||||||
|
Loss from extinguishment
|
|
|
|
|||||||||
|
Other income
|
(
|
)
|
|
|
||||||||
|
Changes in operating assets and liabilities:
|
||||||||||||
|
Decrease (Increase) in accrued severance pay, net
|
|
(
|
)
|
|
||||||||
|
Decrease (Increase) in other assets, other receivables and prepaid expenses
|
(
|
)
|
|
|
||||||||
|
Decrease in accrued interest and amortization of premium on available-for sale marketable securities
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Decrease in operating lease right-of-use asset
|
|
|
|
|||||||||
|
Decrease in operating leases liability
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Decrease (Increase) in trade receivables
|
(
|
)
|
(
|
)
|
|
|||||||
|
Decrease (Increase) in inventories
|
(
|
)
|
|
|
||||||||
|
Decrease in trade payables
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Increase (Decrease) in employees and payroll accruals
|
|
(
|
)
|
(
|
)
|
|||||||
|
Increase (Decrease) in deferred revenues
|
|
|
(
|
)
|
||||||||
|
Increase (Decrease) in other payables and accrued expenses
|
|
(
|
)
|
(
|
)
|
|||||||
|
Gain of foreign exchange on cash and cash equivalents
|
(
|
)
|
|
|
||||||||
|
Net cash provided by (used in) operating activities
|
|
|
(
|
)
|
||||||||
|
Cash flows from investing activities:
|
||||||||||||
|
Decrease (Increase) in restricted deposit
|
(
|
)
|
|
(
|
)
|
|||||||
|
Investment in short-term bank deposits
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Withdrawal in short-term bank deposits
|
|
|
|
|||||||||
|
Purchase of property and equipment
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Investment in available-for sale marketable securities
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Proceeds from redemption of marketable securities
|
|
|
|
|||||||||
|
Proceeds from sale of marketable securities
|
|
|
|
|||||||||
|
Proceeds from sale of patent
|
|
|
|
|||||||||
|
Net cash provided by (used in) investing activities
|
(
|
)
|
(
|
)
|
|
|||||||
| F - 9 |
|
Year ended
December 31,
|
||||||||||||
|
2025
|
2024
|
2023
|
||||||||||
|
Cash flows from financing activities:
|
||||||||||||
|
Issuance of share capital
|
|
|
|
|||||||||
|
Proceeds from exercise of stock options
|
|
|
|
|||||||||
|
Redemption of convertible debt
|
(
|
)
|
|
|
||||||||
|
Net cash provided by financing activities
|
|
|
|
|||||||||
|
Effect of exchange rate changes on cash and cash equivalents
|
|
|
|
|||||||||
|
Increase in cash and cash equivalents
|
|
|
|
|||||||||
|
Cash and cash equivalents at the beginning of the year
|
|
|
|
|||||||||
|
Cash and cash equivalents at the end of the year
|
$
|
|
$
|
|
$
|
|
||||||
|
Supplementary cash flow information:
|
||||||||||||
|
Cash paid/received during the year for:
|
||||||||||||
|
Taxes paid, net
|
$
|
|
$
|
|
$
|
|
||||||
|
Interest received
|
$
|
|
$
|
|
$
|
|
||||||
|
Non-cash activity:
|
||||||||||||
|
ROU asset and lease liability decrease, due to lease termination
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Redemption of convertible debt
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Right-of-use assets obtained in the exchange for operating lease liabilities
|
$
|
|
$
|
|
$
|
|
||||||
| F - 10 |
| NOTE 1: - |
GENERAL
|
| a. |
Allot Ltd. (the "Company") was incorporated in November 1996 under the laws of the State of Israel. The Company is engaged in developing, selling and marketing of leading innovative network intelligence (“Allot Smart”) and security solutions (“Allot Secure”) for mobile and fixed service providers as well as enterprises worldwide. Our solutions are deployed globally for network and application analytics, traffic control and shaping, network-based security including mobile security, distributed denial of service (DDoS) protection, IoT security, and more. Allot Smart generates insightful intelligence that allows CSPs to analyze every packet of network, user, application and security data, CSPs can see, control and secure their networks, optimizing performance, minimizing costs and maximizing end-user QoE. Allot Secure provides security service for the mass market and SMB at home, at work and on the go for mobile, fixed and 5G converged networks. Allot Secure enables customers to detect security breaches and protect networks and network users from attacks.
|
F - 11
| NOTE 1: - |
GENERAL (Cont.)
|
| NOTE 2: - |
SIGNIFICANT ACCOUNTING POLICIES
|
| a. |
Use of estimates:
|
| b. |
Financial statements in U.S. dollars:
|
F - 12
| NOTE 2: - |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
c.
|
Principles of consolidation:
|
|
d.
|
Cash and cash equivalents:
|
|
e.
|
Restricted deposits:
|
| f. |
Short-term bank deposits:
|
|
g.
|
Trade Receivable and Allowances:
|
F - 13
| NOTE 2: - |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
2025
|
2024
|
2023
|
||||||||||
|
Total allowance for credit losses – January 1
|
|
|
|
|||||||||
|
Current-period provision for expected credit losses
|
|
|
|
|||||||||
|
Write-offs
|
(
|
)
|
|
(
|
)
|
|||||||
|
Recoveries collected
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Total allowance for credit losses – December 31
|
|
|
|
|||||||||
|
h.
|
Marketable securities:
|
F - 14
| NOTE 2: - |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
i.
|
Inventories:
|
|
j.
|
Property and equipment, net:
|
|
%
|
|||
|
Lab equipment
|
|
||
|
Computers and peripheral equipment
|
|
||
|
Office furniture
|
|
||
|
SECaaS equipment*
|
|
||
|
Leasehold improvements
|
|
| k. |
Goodwill:
|
F - 15
| NOTE 2: - |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
| l. |
Impairment of long-lived assets, Right-of-use assets, and intangible assets subject to amortization:
|
F - 16
| NOTE 2: - |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
| m. |
Revenue recognition:
|
F - 17
| NOTE 2: - |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
F - 18
| NOTE 2: - |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
n.
|
Cost of revenues:
|
|
o.
|
Research and development costs:
|
|
p.
|
Severance pay:
|
F - 19
| NOTE 2: - |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
q.
|
Accounting for share-based compensation:
|
|
Year ended
December 31,
|
||||||||||||
|
2025
|
2024
|
2023
|
||||||||||
|
Cost of revenues
|
$
|
|
$
|
|
$
|
|
||||||
|
Research and development
|
|
|
|
|||||||||
|
Sales and marketing
|
|
|
|
|||||||||
|
General and administrative
|
|
|
|
|||||||||
|
Total share-based compensation expense
|
$
|
|
$
|
|
$
|
|
||||||
F - 20
| NOTE 2: - |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
r.
|
Treasury share:
|
|
s.
|
Concentration of credit risks:
|
F - 21
| NOTE 2: - |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
t.
|
Government grants:
|
F - 22
| NOTE 2: - |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
u.
|
Income taxes:
|
|
v.
|
Basic and diluted net income (loss) per share:
|
F - 23
| NOTE 2: - |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
w.
|
Comprehensive income (loss):
|
|
Year ended
December 31, 2025
|
||||||||||||
|
Unrealized gain on marketable securities
|
Unrealized gains on cash flow hedges
|
Total
|
||||||||||
|
Balance as of December 31, 2024
|
$
|
|
$
|
|
$
|
|
||||||
|
Changes in other comprehensive income before reclassifications
|
|
|
|
|||||||||
|
Amounts reclassified from accumulated other comprehensive income to:
|
||||||||||||
|
Cost of revenues
|
|
(
|
)
|
(
|
)
|
|||||||
|
Research and development
|
|
(
|
)
|
(
|
)
|
|||||||
|
Sales and marketing
|
|
(
|
)
|
(
|
)
|
|||||||
|
General and administrative
|
|
(
|
)
|
(
|
)
|
|||||||
|
Net current-period other comprehensive income
|
|
|
|
|||||||||
|
Balance as of December 31, 2025
|
$
|
|
$
|
|
$
|
|
||||||
|
x.
|
Fair value of financial instruments:
|
F - 24
| NOTE 2: - |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
| Level 1 - |
Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
|
| Level 2 - |
Include other inputs that are directly or indirectly observable in the marketplace, other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets with insufficient volume or infrequent transactions, or other inputs that are observable (model-derived valuations in which significant inputs are observable), or can be derived principally from or corroborated by observable market data; and
|
| Level 3 - |
Unobservable inputs which are supported by little or no market activity.
|
|
y.
|
Derivatives and hedging:
|
F - 25
| NOTE 2: - |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
| z. |
Business combinations:
|
|
aa.
|
Lease:
|
F - 26
| NOTE 2: - |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
ab.
|
Warranty costs:
|
|
ac.
|
Recently Adopted Accounting Pronouncements:
|
|
ad.
|
Recent Accounting Guidance Not Yet Adopted
|
F - 27
| NOTE 3: - |
AVAILABLE-FOR-SALE MARKETABLE SECURITIES
|
|
December 31, 2025
|
December 31, 2024
|
|||||||||||||||||||||||||||||||
|
Amortized
cost
|
Gross
unrealized
gain
|
Gross
unrealized
loss
|
Fair
Value
|
Amortized
cost
|
Gross
unrealized
gain |
Gross
unrealized
loss
|
Fair
value
|
|||||||||||||||||||||||||
|
Available-for-sale - matures within one year:
|
||||||||||||||||||||||||||||||||
|
US Governmental debentures
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||||||||||
| NOTE 4: - |
FAIR VALUE MEASUREMENTS
|
|
As of December 31, 2025
|
||||||||||||||||
|
Fair value measurements using input type
|
||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Assets:
|
||||||||||||||||
|
Available-for-sale marketable securities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Foreign currency derivative contracts
|
|
|
|
|
||||||||||||
|
Total financial assets
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
F - 28
| NOTE 4: - |
FAIR VALUE MEASUREMENTS (Cont.)
|
|
As of December 31, 2024
|
||||||||||||||||
|
Fair value measurements using input type
|
||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Assets:
|
||||||||||||||||
|
Available-for-sale marketable securities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Foreign currency derivative contracts
|
|
|
|
|
||||||||||||
|
Liabilities:
|
||||||||||||||||
|
Foreign currency derivative contracts
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Total financial net assets
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
| NOTE 5: - |
DERIVATIVE INSTRUMENTS
|
F - 29
| NOTE 5: - |
DERIVATIVE INSTRUMENTS (Cont.)
|
The fair value amounts of outstanding foreign currency contracts in U.S. dollar as of the periods presented were as follows:
|
December 31,
|
December 31,
|
|||||||
|
2025
|
2024
|
|||||||
|
Derivatives Designated as Hedging Instruments
|
||||||||
|
Foreign currency contracts
|
$
|
|
$
|
|
||||
|
Derivatives Not Designated as Hedging Instruments
|
||||||||
|
Foreign currency contracts
|
|
|
||||||
|
Total derivative instruments
|
$
|
|
$
|
|
||||
| NOTE 6: - |
OTHER RECEIVABLES AND PREPAID EXPENSES
|
|
December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Prepaid expenses
|
$
|
|
$
|
|
||||
|
Government authorities
|
|
|
||||||
|
Accrued interest
|
|
|
||||||
|
Foreign currency derivative contracts
|
|
|
||||||
|
Grants receivable from the OCS
|
|
|
||||||
|
Short-term lease deposits
|
|
|
||||||
|
Others
|
|
|
||||||
|
$
|
|
$
|
|
|||||
F - 30
| NOTE 7: - |
INVENTORIES
|
|
December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Raw materials
|
$
|
|
$
|
|
||||
|
Finished goods
|
|
|
||||||
|
$
|
|
$
|
|
|||||
|
NOTE 8: -
|
PROPERTY AND EQUIPMENT, NET
|
|
December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Cost:
|
||||||||
|
Lab equipment
|
$
|
|
$
|
|
||||
|
Computers and peripheral equipment
|
|
|
||||||
|
Office furniture and equipment
|
|
|
||||||
|
Leasehold improvements
|
|
|
||||||
|
SECaaS equipment
|
|
|
||||||
|
|
|
|||||||
|
Accumulated depreciation:
|
||||||||
|
Lab equipment
|
|
|
||||||
|
Computers and peripheral equipment
|
|
|
||||||
|
Office furniture and equipment
|
|
|
||||||
|
Leasehold improvements
|
|
|
||||||
|
SECaaS equipment
|
|
|
||||||
|
|
|
|||||||
|
Depreciated cost
|
$
|
|
$
|
|
||||
F - 31
| NOTE 9: - |
INTANGIBLE ASSETS, NET
|
| a. |
The following table shows the Company's intangible assets for the periods presented
|
|
December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Original Cost:
|
||||||||
|
Technology
|
$
|
|
$
|
|
||||
|
Backlog
|
|
|
||||||
|
Customer relationships
|
|
|
||||||
|
Software license
|
|
|
||||||
|
IP R&D
|
|
|
||||||
|
$
|
|
$
|
|
|||||
|
Accumulated amortization:
|
||||||||
|
Technology
|
$
|
|
$
|
|
||||
|
Backlog
|
|
|
||||||
|
Customer relationships
|
|
|
||||||
|
Software license
|
|
|
||||||
|
IP R&D
|
|
|
||||||
|
$
|
|
$
|
|
|||||
|
Amortized cost
|
$
|
|
$
|
|
||||
| b. |
Amortization expense for the years ended December 31, 2025, 2024 and 2023 were $
|
| NOTE 10: - |
OTHER PAYABLES AND ACCRUED EXPENSES
|
|
December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Accrued expenses
|
$
|
|
$
|
|
||||
|
Onerous contract liability
|
|
|
||||||
|
Government authorities
|
|
|
||||||
|
Foreign currency derivative contracts
|
|
|
||||||
|
Holdback and contingent earnout
|
|
|
||||||
|
Provision for returns
|
|
|
||||||
|
Others
|
|
|
||||||
|
$
|
|
$
|
|
|||||
F - 32
| NOTE 11: - |
LEASE
|
|
Year ended December 31,
|
||||||
|
2025
|
2024
|
|||||
|
Weighted average remaining lease term
|
|
|
||||
|
Weighted average discount rate
|
|
|
|
|
||
|
Year ending December 31,
|
||||
|
2026
|
|
|||
|
2027
|
|
|||
|
2028
|
|
|||
|
2029
|
|
|||
|
2030
|
|
|||
|
Total lease payments
|
|
|||
|
Less - imputed interest
|
(
|
)
|
||
|
Present value of lease liabilities
|
|
|||
F - 33
|
NOTE 12: -
|
COMMITMENTS AND CONTINGENT LIABILITIES
|
|
a.
|
Liens and guarantees:
|
|
b.
|
Litigations:
|
|
NOTE 13:-
|
SHAREHOLDERS' EQUITY
|
| a. |
Company's shares:
|
| b. |
Share option plan:
|
|
Year ended December 31, 2025
|
||||||||
|
Number
of shares upon exercise
|
Weighted average exercise price
|
|||||||
|
Outstanding at beginning of year
|
|
$
|
|
|||||
|
Granted
|
|
$
|
|
|||||
|
Forfeited
|
(
|
)
|
$
|
|
||||
|
Exercised
|
(
|
)
|
$
|
|
||||
|
Outstanding at end of year
|
|
$
|
|
|||||
|
Exercisable at end of year
|
|
$
|
|
|||||
|
Vested and expected to vest
|
|
$
|
|
|||||
F - 34
| NOTE 13: - |
SHAREHOLDERS' EQUITY (Cont.)
|
|
Year ended December 31, 2025
|
||||||||
|
Number
of shares upon exercise
|
Weighted average share price
|
|||||||
|
Outstanding at beginning of year
|
|
$
|
|
|||||
|
Granted
|
|
$
|
|
|||||
|
Vested
|
(
|
)
|
$
|
|
||||
|
Forfeited
|
(
|
)
|
$
|
|
||||
|
Unvested at end of year
|
|
$
|
|
|||||
|
c.
|
Private Placements:
|
| NOTE 14: - |
TAXES ON INCOME
|
| a. |
Corporate tax rates:
|
|
b.
|
Foreign Exchange Regulations:
|
F - 35
| NOTE 14: - |
TAXES ON INCOME (Cont.)
|
|
c.
|
Pre-tax income (loss) is comprised as follows:
|
|
Year ended
December 31,
|
||||||||||||
|
2025
|
2024
|
2023
|
||||||||||
|
Domestic
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Foreign
|
|
|
|
|||||||||
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
|||||
| d. |
A reconciliation of the theoretical tax expenses, assuming all income is taxed at the statutory tax rate applicable to the income of the Company and the actual tax expenses is as follows:
|
|
Year Ended December 31, 2025
|
||||||||
|
Total
|
%
|
|||||||
|
Consolidated pretax income
|
$
|
|
||||||
|
Corporate Statutory Tax Rate
|
|
|
%
|
|||||
|
Foreign tax effects:
|
||||||||
|
Spain
|
||||||||
|
Changes in valuation allowance
|
(
|
)
|
(
|
)%
|
||||
|
Statutory rate difference
|
(
|
)
|
(
|
)%
|
||||
|
Non taxable Grants
|
(
|
)
|
(
|
)%
|
||||
|
Other
|
|
|
%
|
|||||
|
United states:
|
||||||||
|
Share-based payment awards
|
(
|
)
|
(
|
)%
|
||||
|
Change in valuation allowance
|
|
|
%
|
|||||
|
Other
|
(
|
)
|
(
|
)%
|
||||
|
Other foreign jurisdictions
|
|
|
%
|
|||||
|
Changes in valuation allowance
|
(
|
) |
(
|
)%
|
||||
|
Nontaxable or nondeductible:
|
||||||||
|
Goodwill impairment
|
|
|
%
|
|||||
|
Changes in unrecognized tax benefits
|
|
|
%
|
|||||
|
Other Adjustments
|
(
|
)
|
(
|
)%
|
||||
|
Effective tax rate
|
$
|
|
|
%
|
||||
F - 36
| NOTE 14: - |
TAXES ON INCOME (Cont.)
|
|
2024
|
2023
|
|||||||
|
Loss before taxes on income
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Theoretical tax income computed at the Israeli statutory tax rate (23% for the years 2024 and 2023, respectively)
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Changes in valuation allowance
|
|
|
||||||
|
Write off of prepaid and withholding taxes
|
|
|
||||||
|
Foreign tax rates differences related to subsidiaries
|
|
|
||||||
|
Non-deductible expenses
|
(
|
)
|
(
|
)
|
||||
|
Capital note and inter-company balances release taxes
|
|
|
||||||
|
Other expenses and Exchange rate differences
|
|
(
|
)
|
|||||
|
Non-deductible share-based compensation expense
|
|
|
||||||
|
Change in expense associated with tax positions for current year
|
|
|
||||||
|
Actual tax expense
|
$
|
|
$
|
|
||||
| e. |
Taxes on income
|
|
Year ended December 31,
|
||||||||||||
|
2025
|
2024
|
2023
|
||||||||||
|
Current taxes
|
$
|
|
$
|
|
$
|
|
||||||
|
Write off of prepaid and withholding taxes
|
|
|
|
|||||||||
|
Change in expense associated with tax positions for current year
|
|
|
|
|||||||||
|
Other
|
(
|
)
|
|
(
|
)
|
|||||||
|
$
|
|
$
|
|
$
|
|
|||||||
For the year ended December 31, 2025, the total tax paid in cash was $
F - 37
| NOTE 14: - |
TAXES ON INCOME (Cont.)
|
|
Year ended December 31,
|
||||||||||||
|
2025
|
2024
|
2023
|
||||||||||
|
Domestic
|
$
|
|
$
|
|
$
|
|
||||||
|
Foreign
|
|
|
|
|||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
||||||
|
Domestic
|
||||||||||||
|
Write off of prepaid and withholding taxes
|
|
|
|
|||||||||
|
Total Domestic
|
$
|
|
$
|
|
$
|
|
||||||
|
Foreign
|
||||||||||||
|
Current taxes
|
$
|
|
$
|
|
$
|
|
||||||
|
Taxes in respect of previous years
|
(
|
)
|
|
(
|
)
|
|||||||
|
Write off of prepaid and withholding taxes
|
|
|
(
|
)
|
||||||||
|
Change in expense associated with tax positions for current year
|
|
|
|
|||||||||
|
Total foreign
|
$
|
|
$
|
|
$
|
|
||||||
|
Total income tax expense (benefit)
|
$
|
|
$
|
|
$
|
|
||||||
|
f.
|
Net operating losses carry forward:
|
F - 38
| NOTE 14: - |
TAXES ON INCOME (Cont.)
|
| g. |
Deferred income taxes:
|
|
December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Deferred tax assets:
|
||||||||
|
Operating and capital loss carryforwards
|
$
|
|
$
|
|
||||
|
Research and development
|
|
|
||||||
|
Employee benefits
|
(
|
)
|
|
|||||
|
Intangible assets
|
|
|
||||||
|
Operating lease liabilities
|
|
|
||||||
|
Stock based compensation expenses
|
|
|
||||||
|
Onerous contract
|
|
|
||||||
|
Prepaid and withholding taxes
|
|
|
||||||
|
Other temporary differences
|
|
|
||||||
|
Deferred tax asset before valuation allowance
|
|
|
||||||
|
Valuation allowance
|
(
|
)
|
(
|
)
|
||||
|
Deferred tax asset net of valuation allowance
|
|
|
||||||
|
Deferred tax liability:
|
||||||||
|
Intangible assets
|
|
|
||||||
|
Operating lease right-of-use assets
|
|
|
||||||
|
Net deferred tax asset
|
$
|
|
$
|
|
||||
F - 39
| NOTE 14: - |
TAXES ON INCOME (Cont.)
|
| h. |
As of December 31, 2025, the total gross uncertain tax benefits amounted to $
|
|
Year ended
December 31,
|
||||||||||||
|
2025
|
2024
|
2023
|
||||||||||
|
Uncertain tax position, beginning of year
|
$
|
|
$
|
|
$
|
|
||||||
|
Increase related to current years' tax positions
|
|
|
|
|||||||||
|
Increase related to prior years' tax positions
|
|
|
|
|||||||||
|
Decrease due to lapses of statutes limitations
|
|
|
(
|
)
|
||||||||
|
Uncertain tax position, end of year
|
$
|
|
$
|
|
$
|
|
||||||
F - 40
| NOTE 14: - |
TAXES ON INCOME (Cont.)
|
| NOTE 15: - |
GEOGRAPHIC AND SEGMENT INFORMATION
|
|
Year ended
December 31,
|
||||||||||||
|
2025
|
2024
|
2023
|
||||||||||
|
Europe
|
$
|
|
$
|
|
$
|
|
||||||
|
Asia and Oceania
|
|
|
|
|||||||||
|
Americas
|
|
|
|
|||||||||
|
Middle East and Africa
|
|
|
|
|||||||||
|
$
|
|
$
|
|
$
|
|
|||||||
F - 41
| NOTE 15: - |
GEOGRAPHIC AND SEGMENT INFORMATION (Cont.)
|
|
Year ended
December 31,
|
||||||||||||
|
2025
|
2024
|
2023
|
||||||||||
|
1st Customer
|
|
|
|
%
|
||||||||
|
|
|
|
%
|
|||||||||
|
December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Long-lived assets:
|
||||||||
|
Israel
|
$
|
|
$
|
|
||||
|
Other
|
|
|
||||||
|
$
|
|
$
|
|
|||||
| NOTE 16: - |
FINANCIAL INCOME (EXPENSES), NET
|
|
Year ended
December 31,
|
||||||||||||
|
2025
|
2024
|
2023
|
||||||||||
|
Financial income:
|
||||||||||||
|
Interest income
|
$
|
|
$
|
|
$
|
|
||||||
|
Amortization/accretion of premium/discount on marketable securities, net
|
|
|
|
|||||||||
|
Gain on sales of securities
|
|
|
|
|||||||||
|
Exchange rate differences and other
|
|
|
|
|||||||||
|
Financial expenses:
|
||||||||||||
|
Exchange rate differences and other
|
|
|
|
|||||||||
|
Institutions interest Expenses
|
|
|
|
|||||||||
|
$
|
|
$
|
|
$
|
|
|||||||
F - 42
|
NOTE 17: -
|
CONVERTIBLE NOTES
|
|
NOTE 18: -
|
RELATED PARTIES BALANCES AND TRANSACTIONS
|
F - 43